Literature DB >> 32126046

Human allograft refractive lenticular implantation for high hyperopiccorrection.

Majid Moshirfar1, Grant C Hopping, Anisha N Somani, Uma Vaidyanathan, Harry Liu, James R Barnes, Steven Linn, Yasmyne C Ronquillo, Phillip C Hoopes.   

Abstract

Hyperopia is a common form of refractive error in the United States. Many refractive errors can be treated with refractive surgery methods such as laser in-situ keratomileusis and photorefractive keratectomy; however, in patients with large degrees of hyperopia (≥+5.0 diopters [D]), these surgical methods are limited because of higher rates of refractive regression. Lenticule Intrastromal Keratoplasty (LIKE) is a surgical procedure that can be used to correct refractive errors in patients with high hyperopia. The authors describe the first intrastromal implantation of an allograft lenticule performed for the primary correction of hyperopia in the United States, and demonstrate that LIKE is potentially an effective procedure for the correction of high hyperopia. Mechanisms for achieving the intended refractive correction and the complications our patient experienced, including epithelial ingrowth and flap necrosis, are discussed.

Entities:  

Mesh:

Year:  2020        PMID: 32126046     DOI: 10.1097/j.jcrs.0000000000000011

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  Corneal densitometry after allogeneic small-incision intrastromal lenticule implantation for hyperopia correction.

Authors:  Jie Hou; Yan Wang; Jing Zhang; Yulin Lei; Zhixing Ma; Ying Zhang; Xiuyun Zheng
Journal:  BMC Ophthalmol       Date:  2022-06-29       Impact factor: 2.086

2.  Comparison of the Effects of Temperature and Dehydration Mode on Glycerin-Based Approaches to SMILE-Derived Lenticule Preservation.

Authors:  Fei Xia; Jing Zhao; Dan Fu; Bing Qin; Zhi Chen; Yu Zhao; Yang Shen; Jiayun Hou; Xingtao Zhou
Journal:  Cornea       Date:  2022-04-01       Impact factor: 2.651

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.